Back to Zürcher Kantonalbank Zürcher Kantonalbank

SMMT

13 quarters

Position history for Zürcher KantonalbankZürcher Kantonalbank's holdings in Summit Therapeutics Inc.

No. Zürcher Kantonalbank exited its SMMT (Summit Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 424 shares worth $7,416. Zürcher Kantonalbank first reported SMMT in Q1 2023 and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$10,000

Total Shares Change

-5,714

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$18.96
0
2025-Q4
Unchanged
424
0.0%
$7,4160.0%$17.49
0
2025-Q3
Decreased
424
-32.5%
$8,7600.0%$20.66
0
2025-Q2
Decreased
628
-14.7%
$13,3640.0%$21.28
0
2025-Q1
Decreased
736
-86.6%
$14,1970.0%$19.29
0
2024-Q4
Decreased
5,486
-17.0%
$97,8980.0%$17.85
0
2024-Q3
Decreased
6,612
-2.2%
$144,8030.0%$20.89
0
2024-Q2
Decreased
6,760
-82.7%
$52,7280.0%$7.80
0
2024-Q1
Decreased
38,993
-1.9%
$161,4310.0%$4.14
0
2023-Q4
Increased
39,727
+55.0%
$103,6870.0%$2.61
31
2023-Q3
Decreased
25,629
-2.5%
$47,9260.0%$1.87
0
2023-Q2
Increased
26,282
+360.0%
$65,9680.0%$2.51
34
2023-Q1
New
5,714
-
$10,0000.0%$1.63
26

Other major holders of SMMT: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used